Evolution or Revolution? Why Western Psychiatry Will not Change by Incremental Steps

How sensible is it to expect that the biological alter of Western psychiatry can be sustainably altered one small action at a time? House Drug Details Safety and Effectiveness Reviews Withdrawal Resources Links Writers MIA Reports Journalism Initiatives Media Watch

See all stories on this subject FDA hold stops stage 3 study of

ADHD, Fragile X syndrome treatment Alcobra, Ltd. received spoken notification from the FDA’s Department of Psychiatry Products that a complete scientific hold was placed on the Investigational New Drug applications for extended-release metadoxine for ADHD and Delicate X syndrome, according to a company …